This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rödicker, F. Articles by Pützer, B. M. Search for Related Content PubMed PubMed Citation Articles by Rödicker, F. Articles by Pützer, B. M.

p73 Is Effective in p53-null Pancreatic Cancer Cells Resistant to Wild-type TP53 Gene Replacement¹

Centre for Cancer Research and Cancer Therapy, Institute of Molecular Biology, University of Essen, Medical School, D-45122 Essen, Germany

Novel therapies such as gene therapy are needed for the treatment of pancreatic carcinomas. Here we show that adenovirus-mediated p73 overexpression results in a strong induction of apoptosis, whereas the effect of p53 varies between different cell lines. In particular, p53-negative AsPC-1 cells are resistant to p53-mediated apoptosis. In these cells, only ectopically expressed p73 activates the proapoptotic p53 target P53AIP1, whereas phosphorylation of p53 at Ser-46, shown to regulate transcriptional activation of P53AIP1, is missing. Our findings support the use of p73 as an anticancer drug in p53-null pancreatic cancer cells that are resistant to wild-type TP53 gene replacement.

This article has been cited by other articles:

				J. Johnson, J. Lagowski, A. Sundberg, S. Lawson, Y. Liu, and M. Kulesz-Martin p73 Loss Triggers Conversion to Squamous Cell Carcinoma Reversible upon Reconstitution with TAp73{alpha} Cancer Res., August 15, 2007; 67(16): 7723 - 7730. [Abstract] [Full Text] [PDF]

				M. Nakanishi, T. Ozaki, H. Yamamoto, T. Hanamoto, H. Kikuchi, K. Furuya, M. Asaka, D. Delia, and A. Nakagawara NFBD1/MDC1 Associates with p53 and Regulates Its Function at the Crossroad between Cell Survival and Death in Response to DNA Damage J. Biol. Chem., August 3, 2007; 282(31): 22993 - 23004. [Abstract] [Full Text] [PDF]

				T. Racek, N. Mise, Z. Li, A. Stoll, and B. M. Putzer C-terminal p73 Isoforms Repress Transcriptional Activity of the Human Telomerase Reverse Transcriptase (hTERT) Promoter J. Biol. Chem., December 9, 2005; 280(49): 40402 - 40405. [Abstract] [Full Text] [PDF]

				K T M Johnson, F Rodicker, K Heise, C Heinz, K-P Steuhl, B M Putzer, and T Hudde Adenoviral p53 gene transfer inhibits human Tenon's capsule fibroblast proliferation Br. J. Ophthalmol., April 1, 2005; 89(4): 508 - 512. [Abstract] [Full Text] [PDF]

				M. Drosten, G. Hilken, M. Bockmann, F. Rodicker, N. Mise, A. N. Cranston, U. Dahmen, B. A. J. Ponder, and B. M. Putzer Role of MEN2A-Derived RET in Maintenance and Proliferation of Medullary Thyroid Carcinoma J Natl Cancer Inst, August 18, 2004; 96(16): 1231 - 1239. [Abstract] [Full Text] [PDF]

				U. M. Moll and N. Slade p63 and p73: Roles in Development and Tumor Formation Mol. Cancer Res., July 1, 2004; 2(7): 371 - 386. [Abstract] [Full Text] [PDF]